1. Department of Health and Human Services, U.S. Food and Drug Administration (2007) Pharmaceutical quality for 21st Century a risk based approach progress report.
http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm128080.htm
. Accessed 8 Feb 2017
2. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline (2009) Pharmaceutical development Q8 (R2). ICH, Geneva
3. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline (2005) Quality risk management Q9. ICH, Geneva
4. International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline (2008) Pharmaceutical quality system Q10. ICH, Geneva
5. Rozet E, Lebrun P, Debrus B, Boulanger P, Hubert P (2013) Design spaces for analytical methods. Trac-Trend Anal Chem 42:157–167